Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Goldstein Joseph l, Director. Officer active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 10 disclosures have been recorded. Activity tracked since 7 June 2021. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Joseph L. Goldstein serves as a Director at REGENERON PHARMACEUTICALS, INC. In this role, he contributes to the governance of the company and oversight of its operations. Goldstein plays a key role in developing the strategies and policies that guide the company in the pharmaceutical sector, ensuring that shareholder interests are protected.